REFERENCES
- Goodman LS, Gilman A: The Pharmacological Basis of Therapeutics. New York, The Macmillan Company, 1941, p 163
- Borrus JC: Study of effect of Miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states. JAMA 157: 1596, 1955
- Selling LS, Clinical study of a new tranquilizing drug, Use of Miltown (2-methyl-2-n-propyl-1,3 propanediol dicarbamate). JAMA 157: 1594, 1955
- Klerman GL, DiMascio A, Havens LL, et al: Sedation and tranquilization, A comparison of the effects of a number of psychopharmacologic agents upon normal human subjects. Arch Gen Psychiatry 3: 4, 1960
- Domino EF: Human pharmacology of tranquilizing drugs. Clin Pharmacol Ther 3: 599, 1963
- Tobin JM, Lewis ND: New psychotherapeutic agent, chlordiazepoxide, Use in treatment of anxiety states and related symptoms. JAMA 174, 1242, 1960
- Randall LO, Schallek W: Pharmacological activity of certain benzodiazepines. In Efron DH, Cole JD, Levine J, et al (Editors), Psychopharmacology, A Review of Progress 1957–1967. Publication 1836, United States Public Health Service, 1968, p 153
- Elliott HW, Nomof N, Navarro G, et al: Central nervous system and cardiovascular effects of lorazepam in man. Clin Pharmacol Ther 12: 468, 1971
- Zbinden G, Bagdon RE, Keith EF, et al: Experimental and clinical toxicology of chlordiazepoxide (Librium). Toxicol Appl Pharmacol 3: 619, 1961
- Irwin S: Anti-neurotics, Practical pharmacology of the sedative-hypnotics and minor tranquilizers. In Efron et al (Editors),7 p 185
- Gupta RC, Kofoed J: Toxicological statistics for barbiturates, other sedatives, and tranquilizers in Ontario, A 10-year survey. Can Med Assoc J 94: 863, 1966
- Berger FM: Drugs and suicide in the United States. Clin Pharmacol Ther 8: 219, 1967
- Comer WH, Elliott HW, Nomof N, et al: Pharmacology of parenterally administered lorazepam in man. J Int Med Res (in press)
- Parker KD, Elliott HW, Wright JA, et al: Blood and urine concentrations of subjects receiving barbiturates, meprobamate, glutethimide or diphenylhydantoin. Clin Toxicol 3: 131, 1970
- Bieger R, Jonge H de, Loeliger EA: Influence of nitrazepam on oral anticoagulation with phenprocoumon. Clin Pharmacol Ther 13: 361, 1972
- Breckenridge A, Orme M: Clinical implications of enzyme induction. Ann NY Acad Sci 179: 421, 1971
- Jori A, Prestini PE, Pugliatti C: Effect of diazepam and chlordiazepoxide on the metabolism of other drugs. J Pharm Pharmacol 21: 387, 1969
- Hollister LE: Clinical use of psychotherapeutic drugs, Current status. Clin Pharmacol Ther 10, 170, 1969
- Meyers FH, Jawetz E, Goldfien A: Review of Medical Pharmacology. Ed 3. Los Altos, Calif, Lange Medical Publications, 1972, p 219
- Rickeis K: Antineurotic agents, Specific and non-specific effects. In Efron et al (Editors),7 p 231
- Gottschalk LA: Psychoactive drugs in outpatient therapy. Psychiatry Med 2: 116, 1971
- Antianxiety drugs in organic and functional syndromes. Med Lett Drugs Ther 14: 93, Dec 1972